Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,844 total, page 35 of 57
The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes
NCT02762708
Gut Permeability Assessment in Celiac and Gluten Sensitive Children
NCT02690532
Stress Management Intervention in Women's Heart Clinic, Heart SMART Program
NCT02670421
Chronic Inflammation and Exercise Responsiveness
NCT02732509
Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake
NCT02517593
Advanced MR Imaging in Sarcoma Patients
NCT02705391
SBRT for Oligometastatic Castration-Refractory Prostate Cancer
NCT02816983
Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer
NCT02671890
A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing
NCT02705404
Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy
NCT02649387
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors
NCT02650635
Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
NCT02254239
Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis
NCT03122873
Metformin for the Prevention of Episodic Migraine (MPEM)
NCT02593097
Evaluation of the Relationship Between Vaginal and Lower Urinary Tract Microbiomes and Infection After Hysterectomy
NCT02751073
Use of F-652 in Patients With Alcoholic Hepatitis
NCT02655510
Patient Perception of Video Advance Care Planning
NCT02692950
Adolescent Mental Health InSciEd Out
NCT02680899
IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy
NCT02697292
Screening for Metabolic Problems in Mothers of Children With Autism and Typically Developing Children
NCT02674022
Cardiotoxic Effects of Chemotherapy in Patients With Sarcomas: A Two and Three-dimensional Echocardiographic Speckle Tracking Imaging Study
NCT06511388
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
NCT02652715
Staging Procedures to Diagnose Malignant Pleural Mesothelioma
NCT02648763
Spinal Cord Injury Epidural Stimulation
NCT02592668
Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts
NCT02661529
Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies
NCT02623803
Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP)
NCT02589119
Esophageal Motility in Reflux Induced Cough
NCT02492126
Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications
NCT02094118
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
NCT02646319
Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
NCT02633059
Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation
NCT02634827
Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia
NCT02547662
Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
NCT02647944
Effect of Cueing on Gluteus Maximus Recruitment
NCT02645188
Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services
NCT02752997
InBody Validation Study
NCT02635958
Cytosponge and Dietary Therapy in EoE
NCT02599558
The Role of Therapy for Muscle Tension Dysphagia
NCT02647931
A Study of Colesevelam in Fecal Incontinence
NCT02628626
Objective Measure of Recovery After Outpatient Surgery
NCT02616406
Use of a Shear Reduction Surface in Pre-hospital Transport
NCT02591641
Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
NCT02616705
IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
NCT02625428
Osteoclast Inhibition and Bone Formation
NCT02554695
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
NCT02560623
Peripheral Nerve Stimulation to Reduce Hypoxic Events
NCT02554110
Club Fit: Physical Activity and Healthy Eating at an After School Program
NCT03189979
Corticosteroid/Ropivacaine Versus Corticosteroid/Saline Injections for Knee Osteoarthritis
NCT02576249
Root Coverage Using a Xenograph for Treatment of Gingival Recession
NCT02657395
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.